Literature DB >> 20716206

Aspergillus fumigatus: contours of an opportunistic human pathogen.

Allison McCormick1, Jürgen Loeffler, Frank Ebel.   

Abstract

Aspergillus fumigatus is currently the major air-borne fungal pathogen. It is able to cause several forms of disease in humans of which invasive aspergillosis is the most severe. The high mortality rate of this disease prompts increased efforts to disclose the basic principles of A. fumigatus pathogenicity. According to our current knowledge, A. fumigatus lacks sophisticated virulence traits; it is nevertheless able to establish infection due to its robustness and ability to adapt to a wide range of environmental conditions. This review focuses on two crucial aspects of invasive aspergillosis: (i) properties of A. fumigatus that are relevant during infection and may distinguish it from non-pathogenic Aspergillus species and (ii) interactions of the pathogen with the innate and adaptive immune systems.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20716206     DOI: 10.1111/j.1462-5822.2010.01517.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  54 in total

1.  SREBP-dependent triazole susceptibility in Aspergillus fumigatus is mediated through direct transcriptional regulation of erg11A (cyp51A).

Authors:  Sara J Blosser; Robert A Cramer
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

2.  A new approach to assess occupational exposure to airborne fungal contamination and mycotoxins of forklift drivers in waste sorting facilities.

Authors:  Carla Viegas; Tiago Faria; Ana Cebola de Oliveira; Liliana Aranha Caetano; Elisabete Carolino; Anita Quintal-Gomes; Magdalena Twarużek; Robert Kosicki; Ewelina Soszczyńska; Susana Viegas
Journal:  Mycotoxin Res       Date:  2017-07-20       Impact factor: 3.833

3.  Some fungi in the air. Interview by Sophia Häfner.

Authors:  Robert A Cramer; Tobias M Hohl
Journal:  Microbes Infect       Date:  2013-01-29       Impact factor: 2.700

Review 4.  Developmental regulators in Aspergillus fumigatus.

Authors:  Hee-Soo Park; Jae-Hyuk Yu
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

5.  Molecular characterization of the putative transcription factor SebA involved in virulence in Aspergillus fumigatus.

Authors:  Taísa Magnani Dinamarco; Ricardo S Almeida; Patrícia Alves de Castro; Neil Andrew Brown; Thaila Fernanda dos Reis; Leandra Naira Zambelli Ramalho; Marcela Savoldi; Maria Helena S Goldman; Gustavo Henrique Goldman
Journal:  Eukaryot Cell       Date:  2012-02-17

6.  A case of tracheobronchial aspergillosis resolved spontaneously in an immunocompetent host.

Authors:  Hwa Young Lee; Hyeon Hui Kang; Ji Young Kang; Sung Kyoung Kim; Su Hyun Lee; Yoon Yung Chung; Hye Seon Kang; Hee Sun Kwon; Hwa Sik Moon; Sang Haak Lee
Journal:  Tuberc Respir Dis (Seoul)       Date:  2012-11-30

Review 7.  Aspergillus Species in Bronchiectasis: Challenges in the Cystic Fibrosis and Non-cystic Fibrosis Airways.

Authors:  Sanjay H Chotirmall; Maria Teresa Martin-Gomez
Journal:  Mycopathologia       Date:  2017-05-17       Impact factor: 2.574

Review 8.  Invasive pulmonary aspergillosis: current diagnostic methodologies and a new molecular approach.

Authors:  S Moura; L Cerqueira; A Almeida
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-13       Impact factor: 3.267

Review 9.  Allergic Inflammation in Aspergillus fumigatus-Induced Fungal Asthma.

Authors:  Sumit Ghosh; Scott A Hoselton; Jane M Schuh
Journal:  Curr Allergy Asthma Rep       Date:  2015-10       Impact factor: 4.806

10.  Disparate proteome responses of pathogenic and nonpathogenic aspergilli to human serum measured by activity-based protein profiling (ABPP).

Authors:  Susan D Wiedner; Charles Ansong; Bobbie-Jo Webb-Robertson; LeeAnna M Pederson; Suereta Fortuin; Beth A Hofstad; Anil K Shukla; Ellen A Panisko; Richard D Smith; Aaron T Wright
Journal:  Mol Cell Proteomics       Date:  2013-04-18       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.